MOXIZEST L OPHTHALMIC SUSPENSION is a combination of Loteprednol and Moxifloxacin which belongs to the group of medicines called Corticosteroids and Antibiotics respectively. MOXIZEST L OPHTHALMIC SUSPENSION is used in the treatment of postoperative steroid responsive inflammatory ocular infections or risk of bacterial ocular infections exists.
Before using MOXIZEST L OPHTHALMIC SUSPENSION, your doctor may want you to take relevant tests to understand your existing condition. Do not wear contact lenses if you have an active eye infection or while using this medicine.
MOXIZEST L OPHTHALMIC SUSPENSION is not recommended for use in patients with viral diseases of the cornea and conjunctiva including epithelial herpes simplex keratitis (dendritic keratitis), vaccinia, and varicella, and also in mycobacterial infection of the eye and fungal diseases of ocular structures.
Before using MOXIZEST L OPHTHALMIC SUSPENSION, inform your doctor if you have diabetes, increased pressure in the eye, glaucoma, damage of nerves supplying the eye, any visual disturbances, cataract, delay in healing, pus discharge from the eye.
There are no adequate data available for the use of MOXIZEST L OPHTHALMIC SUSPENSION during pregnancy, lactation and in infants. Consult your doctor before using this medicine.
Prolonged use of MOXIZEST L OPHTHALMIC SUSPENSION may result in overgrowth of non-susceptible organisms, including fungi. Cataract formation and delayed wound healing can happen with prolonged usage.
The most common side effects of using MOXIZEST L OPHTHALMIC SUSPENSION are decreased visual acuity, dry eye, keratitis, ocular discomfort, ocular hyperemia, ocular pain, ocular pruritus, sub-conjunctival hemorrhage, tearing, optic nerve damage. Consult your doctor if any of the above side effects worsen.